Dermal Cell News 6.03 January 27, 2020 | |
| |
TOP STORYHyperactivation of Sympathetic Nerves Drives Depletion of Melanocyte Stem Cells Using a combination of adrenalectomy, denervation, chemogenetics, cell ablation and knockout of the adrenergic receptor specifically in melanocyte stem cells, scientists found that the stress-induced loss of melanocyte stem cells was independent of immune attack or adrenal stress hormones. [Nature] Abstract | Press Release | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)DERMAL STEM CELLS & TISSUE REGENERATIONIn vitro experiments revealed that FATP4 exhibited acyl-CoA synthetase activity toward an ω-hydroxy fatty acid, an intermediate of the acylceramide synthetic pathway. Fatp4 knockout mice exhibited severe skin barrier dysfunction and morphological abnormalities in the epidermis. [Proc Natl Acad Sci USA] Abstract Researchers evaluated the cell viability of fibroblasts in the presence of LNnT. The full-thickness wound model was created by punch biopsy. They showed that LNnT had no negative effect on the cell viability of fibroblasts. [Sci Rep] Full Article Phospholipase A2 from Bee Venom Increases Poly(I:C)-Induced Activation in Human Keratinocytes Investigators demonstrated that bee venom-sphospholipase A2 increased the intracellular uptake of polyinosinic-polycytidylic acid (poly(I:C)), phosphorylation of the nuclear factor-kappa B and mitogen-activated protein kinases, and poly(I:C)-mediated IL-8 production in human keratinocytes. [Int Immunol] Abstract Skin stimulation ex vivo with the neuropeptide substance P, mimicking neurogenic skin inflammation, significantly increased the number of CD68+ macrophages in the papillary dermis without altering intracutaneous macrophage proliferation or apoptosis. [PLoS One] Full Article SKIN CANCERS & DISORDERSIncreased expression of sphingosine kinase-1 in tumor cells was significantly associated with shorter survival in metastatic melanoma patients treated with anti-PD-1. Targeting sphingosine kinase-1 markedly enhanced the responses to immune checkpoint inhibitors in murine models of melanoma, breast and colon cancer. [Nat Commun] Full Article Nedd4 Ubiquitylates VDAC2/3 to Suppress Erastin-Induced Ferroptosis in Melanoma Investigators showed that Nedd4 was induced following erastin treatment, which led to the ubiquitination and subsequent degradation of the channels. Depletion of Nedd4 limited the protein degradation of VDAC2/3, which increased the sensitivity of cancer cells to erastin. [Nat Commun] Full Article Apigenin Protects Human Melanocytes against Oxidative Damage by Activation of the Nrf2 Pathway The capacity of apigenin, a plant-derived aglycone, to inhibit oxidative stress-mediated melanocyte depletion in vitro using a PIG3V vitiligo perilesional melanocyte cell model was evaluated. [Cell Stress Chaperones] Abstract The authors formulated hesperetin with inactivated B16F10 melanoma cells and determined whether it would enhance the activation of antigen presenting cells by experiments in vivo and in vitro. [Scand J Immunol] Abstract Subscribe to one of our other 19 science newsletters such as Extracellular Matrix News & Cancer Stem Cell News. | |
| |
REVIEWSWell-balanced nutrition and additional anti-inflammatory polyunsaturated fatty acids-based supplementation should be encouraged in a targeted manner for individuals in need to provide better management of skin diseases and to maintain and improve overall skin health. [Int J Mol Sci] Full Article Visit our reviews page to see a complete list of reviews in the dermal cell research field. | |
| |
INDUSTRY NEWSEpizyme, Inc. announced that the FDA has granted accelerated approval of tazemetostat for the treatment of adults and pediatric patients aged 16 years and older with metastatic or locally advanced epithelioid sarcoma not eligible for complete resection, based on overall response rate and duration of response in a Phase II clinical trial. [Epizyme, Inc.] Press Release The Janssen Pharmaceutical Companies announced that the European Commission has approved the expanded use of ustekinumab for the treatment of paediatric patients with moderate to severe plaque psoriasis. [The Janssen Pharmaceutical Companies] Press Release | |
| |
POLICY NEWSBrazil’s Pick of a Creationist to Lead Its Higher Education Agency Rattles Scientists The appointment of a creationism advocate to lead the agency that oversees Brazil’s graduate study programs has scientists here concerned-yet again-about the encroachment of religion on science and education policy. President Jair Bolsonaro’s administration on Saturday January 25th named Benedito Guimarães Aguiar Neto to head the agency, known as CAPES, who previously served as the rector for a private religious school which advocates the teaching and study of intelligent design. [ScienceInsider] Editorial US Officials Revisit Rules for Disclosing Risky Disease Experiments US disease researchers are pushing the government to be more transparent about federally funded research that involves making pathogens more deadly or more transmissible. Several disease researchers who attended a recent meeting to discuss transparency around such studies say the US government should offer a public explanation when it approves such ‘gain-of-function’ experiments, disclose who made the decision to fund them and make a broad public announcement when a study begins. [Nature News] Editorial Wuhan Scientists: What It’s Like to Be on Lockdown Chinese authorities have closed off travel into and out of the virus-hit city of Wuhan in an attempt to stop the outbreak’s spread. Nature spoke to three researchers about what it’s like to be inside Wuhan right now – and talked to one who is trying to get back in. [Nature News] Editorial Animal Rights Conflict Prompts Leading Researcher to Leave Germany for China A prominent neuroscientist whose German lab was targeted by animal rights activists is heading to China, where he says he will be freer to pursue his work on macaques and other monkeys. Nikos Logothetis, a director at the Max Planck Institute for Biological Cybernetics in Tübingen, Germany, told colleagues last week that the first members of his lab would move in the coming months to a new International Center for Primate Brain Research in Shanghai. [ScienceInsider] Editorial
| |
EVENTSNEW EACR-AACR Basic and Translational Research Conference 2020 Conference: Tumor Microenvironment Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW Researcher – Dermatopathology (Weill Cornell Medical College) NEW Postdoctoral Fellow – Cancer Pathogenesis (University of Cincinnati) Postdoctoral Position – Tissue Repair and Inflammation (Memorial Sloan Kettering Cancer Center) Postdoctoral Fellow – Cancer Research (University of California San Diego Moores Cancer) Research Fellow – Inherited Skin Conditions (University College London) Postdoctoral Fellowship – DNA Repair in Skin Melanoma Prevention (University of Southern California) Postdoctoral Position – Microbiota and Autoimmunity (The University of Arizona) Chief Position – Allergy, Immunology, Rheumatology and Dermatology (Harvard Medical School) Senior Associate Researcher – Inflammatory Skin Diseases (Icahn School of Medicine at Mount Sinai) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Dermal Cell News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|